Caldwell Sutter Capital, Inc. Brainstorm Cell Therapeutics Inc. Call Options Transaction History
Caldwell Sutter Capital, Inc.
- $208 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BCLI
# of Institutions
52Shares Held
4.09MCall Options Held
63.2KPut Options Held
800-
Vanguard Group Inc Valley Forge, PA1.4MShares$476,3370.0% of portfolio
-
Black Rock Inc. New York, NY489KShares$166,3660.0% of portfolio
-
Geode Capital Management, LLC Boston, MA357KShares$121,3930.0% of portfolio
-
Liberty Wealth Management LLC Oakland, CA340KShares$115,6510.04% of portfolio
-
Weaver Consulting Group199KShares$67,7810.04% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $12.4M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...